<scp>GelMA</scp> Hydrogel Encapsulating <scp>iPSC</scp> ‐Derived Human Spinal Cord Organoids Enhances Neural Regeneration and Restores Motor Function in Rat Spinal Cord Injury

Spinal cord injury (SCI) severely compromises neural regeneration due to limited intrinsic repair capacity. Combining induced pluripotent stem cell (iPSC)-derived organoids with biomaterial scaffolds offers a promising regenerative strategy. This study investigated the therapeutic potential of human spinal cord organoids (hSCOs) encapsulated within gelatin methacryloyl (GelMA) hydrogel for SCI repair. hSCOs were generated from iPSCs via stage-specific patterning (dorsoventral inhibition followed by retinoic acid/SAG-induced motor neuron specification) and encapsulated in GelMA hydrogel. The therapeutic efficacy of hSCOs/GelMA composites was evaluated in a rat T10 contusion SCI model (n = 6/group: Sham, SCI, GelMA-only, GelMA+hSCOs). Functional recovery was assessed weekly for 4 weeks using Basso-Beattie-Bresnahan (BBB) locomotor scores and inclined plane tests. Histological (H&E, Nissl) and immunofluorescence analyses (Tuj1, GFAP, NF200, CD68) quantified tissue repair, neuronal regeneration, astrogliosis, and neuroinflammation at the lesion site. hSCOs expressed key spinal cord markers (OLIG2, NKX6.1, Tuj1, Islet1) and maintained high viability within GelMA hydrogels. Implantation of GelMA+hSCOs composites significantly enhanced functional recovery (improved BBB scores and inclination angles) and reduced lesion volume compared to both SCI and GelMA-only controls. Immunofluorescence revealed that GelMA+hSCOs treatment promoted neuronal integration (increased density of Tuj1<sup>+</sup> neurons and NF200<sup>+</sup> neurofilaments), attenuated astrogliosis (reduced GFAP<sup>+</sup> scarring), and suppressed neuroinflammation (decreased CD68<sup>+</sup> macrophages) at the injury epicenter relative to control groups. The integration of iPSC-derived hSCOs with GelMA hydrogel significantly promotes structural and functional recovery after SCI by facilitating neuronal survival and integration, mitigating glial scar formation, and modulating the inflammatory response. This combinatorial organoid-hydrogel approach demonstrates substantial translational potential for neural repair strategies.

Authors

Institutions

Publication Details

Journal
Journal of Biomedical Materials Research Part A
Published
2025-10-01
DOI
https://doi.org/10.1002/jbm.a.38001
Citations
3
Primary Topic
Tissue Engineering and Regenerative Medicine
Type
article
Field-Weighted Citation Impact
6.02
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

GelMA Hydrogel Encapsulating iPSC ‐Derived Human Spinal Cord Organoids Enhances Neural Regeneration and Restores Motor Function in Rat Spinal Cord Injury

Yifan Gu, Run Feng, Y. Wang, Min Yang et al.
3 citations
Journal of Biomedical Materials Research Part A
Tissue Engineering and Regenerative Medicine
6.02
article

GelMA Hydrogel Encapsulating iPSC ‐Derived Human Spinal Cord Organoids Enhances Neural Regeneration and Restores Motor Function in Rat Spinal Cord Injury

Yifan Gu, Run Feng, Y. Wang, Min Yang, Kun Wang, Ziru Wang, Shuai Jiang, Yu Zheng, Yi‐Heng Li
article en
3 citations

Abstract

Spinal cord injury (SCI) severely compromises neural regeneration due to limited intrinsic repair capacity. Combining induced pluripotent stem cell (iPSC)-derived organoids with biomaterial scaffolds offers a promising regenerative strategy. This study investigated the therapeutic potential of human spinal cord organoids (hSCOs) encapsulated within gelatin methacryloyl (GelMA) hydrogel for SCI repair. hSCOs were generated from iPSCs via stage-specific patterning (dorsoventral inhibition followed by retinoic acid/SAG-induced motor neuron specification) and encapsulated in GelMA hydrogel. The therapeutic efficacy of hSCOs/GelMA composites was evaluated in a rat T10 contusion SCI model (n = 6/group: Sham, SCI, GelMA-only, GelMA+hSCOs). Functional recovery was assessed weekly for 4 weeks using Basso-Beattie-Bresnahan (BBB) locomotor scores and inclined plane tests. Histological (H&E, Nissl) and immunofluorescence analyses (Tuj1, GFAP, NF200, CD68) quantified tissue repair, neuronal regeneration, astrogliosis, and neuroinflammation at the lesion site. hSCOs expressed key spinal cord markers (OLIG2, NKX6.1, Tuj1, Islet1) and maintained high viability within GelMA hydrogels. Implantation of GelMA+hSCOs composites significantly enhanced functional recovery (improved BBB scores and inclination angles) and reduced lesion volume compared to both SCI and GelMA-only controls. Immunofluorescence revealed that GelMA+hSCOs treatment promoted neuronal integration (increased density of Tuj1<sup>+</sup> neurons and NF200<sup>+</sup> neurofilaments), attenuated astrogliosis (reduced GFAP<sup>+</sup> scarring), and suppressed neuroinflammation (decreased CD68<sup>+</sup> macrophages) at the injury epicenter relative to control groups. The integration of iPSC-derived hSCOs with GelMA hydrogel significantly promotes structural and functional recovery after SCI by facilitating neuronal survival and integration, mitigating glial scar formation, and modulating the inflammatory response. This combinatorial organoid-hydrogel approach demonstrates substantial translational potential for neural repair strategies.

Journal of Biomedical Materials Research Part AVol. 113(10)
First Affiliated Hospital of Wannan Medical College (CN)
Openalex Percentile: Top 3%
Tissue Engineering and Regenerative Medicine
6.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.